検索ワード: ld (ラトビア語 - 英語)

ld”.
ld’.

ld n= 325
n = 325

e-ld n= 321
e-ld n = 321

ld gaismas detektors
ld light detector

pom + ld-dex (n = 302)
hd-dex (n=153)

(ld) 2. panta da) punkts
(ku) article 2(da)

pom + ld-dex salīdz. ar hd-dex
pom+ld-dex vs hd-dex

izņemts ld, wd, eu, du, cu, nt, nc
removed ld, wd, eu, du, cu, nt, nc

, kuru ju rid is k va ld ē in ā jums n e iz
, he ca n m a ke a sp e cia l x p e c e of the union or e g o in f

pfizer bv rivium westlaan 142 2909 ld capelle a/ d
pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel

pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel
pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel

pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel niderlande
pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel the netherlands

ld muguras muskuļu biezums milimetros, ko mēra tajā pašā laikā un vietā kā bf.
ld the thickness of the dorsal muscle in millimetres, measured at the same time and in the same place as bf.

pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel the netherlands niderlande
pfizer bv rivium westlaan 142 2909 ld capelle a/ d ijssel the netherlands

ld minimālais muskuļu biezums milimetros starp gluteus medius muskuļa pakaļējo ekstremitāti un muguras smadzeņu kanāla dorsālo daļu.
ld the minimal muscle depth in millimetres between the anterior extremity of the m. gluteus medius and the dorsal part of medullar canal.

pfizer consumer healthcare bv rivium westlaan 142 nl- 2909 ld capelle a/ d ijsel nīderlande
pfizer consumer healthcare bv rivium westlaan 142 nl-2909 ld capelle a/ d ijsel nederland

toremifēna akūtā toksicitāte ir zema, ld-50 pelēm un žurkām ir vairāk kā 2000 mg/kg.
the acute toxicity of toremifene is low with ld-50 in rats and mice of more than 2000 mg/kg.

, vai ja tā p ār k va ld ē no rād a uz p ār a e ir ri m in ēšan u ļū d ap ār w w . ombuds m an .eu r o p as ombuda tīm ek
h h a a o m p la in t u n n e c fa ilu r a b u se of p o d iscrim in a tio n u n fa irn e ss a d m in istra tiv c u rs if a n institution fa ils t t t u ro p e a n ombudsman in u ro p e a n ombudsman ca n not in re fu sa l of in f e rs.

notikumi: pom + ld-dex = 164/302 hd-dex = 103/153
km median: pom+ld-dex=ne [48.1, ne] km median: hd-dex = 34.0[23.4, 39.0] events: pom+ld-dex=75/284 hd-dex=56/139

otrajā pētījumā pacientus randomizēti sadalīja pa grupām, kas saņēma placebo (229 pacienti), 1 mg rasagilīna dienā (231 pacients) vai 200 mg katehol-o-metil transferāzes (comt) inhibitora entakapona, ko lietoja kopā ar plānotām levodopas (ld)/dekarboksilāzes inhibitora devām (227 pacienti), un ārstēšanu veica 18 nedēļas.
in study ii, patients were randomly assigned to receive placebo (229 patients), or rasagiline 1 mg/day (231 patients) or the catechol-o–methyl transferase (comt) inhibitor, entacapone, 200 mg taken along with scheduled doses of levodopa (ld)/decarboxylase inhibitor (227 patients), and were treated for 18 weeks.